Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
Tack JanHans TornblomVictoria TanFlorencia CarbonePublished in: The American journal of gastroenterology (2022)
Food ingestion is a major symptom trigger in functional esophageal and gastroduodenal disorders and gastroparesis. This review summarizes current knowledge and identifies areas of research on the role of food factors and the opportunities for dietary intervention in these disorders. While many patients experiencing functional esophageal and gastroduodenal disorders identify specific food items as symptom triggers, available data do not allow the identification of specific nutrient groups that are more likely to induce symptoms. In functional dyspepsia (FD), recent studies have shown the potential efficacy of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, although the underlying mechanism of action is unclear. Reports of favorable responses to gluten elimination in patients with FD are confounded by the concomitant benefit of reduced intake of fructans, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols present in wheat. Emerging data based on a 6-food elimination diet and confocal laser endomicroscopic evaluation of mucosal responses to food proteins suggest a role for duodenal allergic reactions in FD symptom generation. In patients with gastroparesis, a low-residue diet has been shown to improve symptoms. Novel dietary approaches under evaluation are the Mediterranean diet and the heating/cooling diet approach.
Keyphrases
- human health
- weight loss
- physical activity
- end stage renal disease
- risk assessment
- randomized controlled trial
- chronic kidney disease
- healthcare
- electronic health record
- ejection fraction
- patient reported
- big data
- machine learning
- sleep quality
- gene expression
- optical coherence tomography
- genome wide
- depressive symptoms
- high speed
- body mass index
- high resolution
- artificial intelligence
- adverse drug
- raman spectroscopy
- amino acid
- blood brain barrier
- patient reported outcomes